CorMedix Inc.
CRMD$576M
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaPARSIPPANY
Drugs in Pipeline
3
Phase 3 Programs
2
Upcoming Catalysts
1
Next Catalyst
Jan 15, 2027
44wMarket Overview
Stock performance and key metrics
CRMD News
Catalyst Timeline
1 upcoming, 1 past
Drug Pipeline
(taurolidine and heparin) catheter lock solution
Central Line Associated Blood Stream Infections (CLABSI)
Neutrolin
Kidney Failure, Chronic
CRMD-001-Deferiprone
Contrast-Induced Acute Kidney Injury
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
(taurolidine and heparin) catheter lock solution | Phase 3 | Central Line Associated Blood Stream Infections (CLABSI) | - | - |
Neutrolin | Phase 3 | Kidney Failure, Chronic | - | - |
CRMD-001-Deferiprone | Phase 2 | Contrast-Induced Acute Kidney Injury | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply